Agents such as benzodiazepines, sedative-hypnotics, antihypertensives, and other psychoactive drugs—often used to treat comorbidities in patients with COPD—may be contributing to an increased risk of falls among this population near the end of life.
Key trial data and insights behind US Food and Drug Administration approvals of novel psychiatric drugs are shown, highlighting methods, demographics, and pivotal outcomes.
"An individual’s simple subjective feeling of poor sleep quality was associated with increased systolic blood pressure in participants aged ≤ 49 years with optimal sleep duration," concluded researchers.
A large cohort study finds no link between montelukast use and neuropsychiatric adverse events in children, supporting its safety for asthma and allergic rhinitis management.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The U.S. Department of Health and Human Services has initiated a broad pause in public communications and travel, disrupting meetings, publications, and research funding approvals affecting human and animal health.
"These findings highlight the need to identify biological mechanisms contributing to sex specificity to facilitate risk stratification, targeted drug development, and improved management of long COVID," wrote the study's authors.